Bringing precision medicine closer to clinical reality

Sanna Gudmundsson studies how subtle changes in DNA lead to disease—and why some individuals remain unaffected despite carrying disease variants. Driven by the ambition to improve diagnostics, her work aims to enable earlier and more accurate identification of genetic conditions, bringing precision medicine closer to clinical reality.

What made you decide to come to KI?
"What truly attracted me to KI was its unique combination of strong international research, advanced infrastructure and close clinical integration. There is an exceptional collection of omics data from patients with rare diseases and the collaborative environment with world-class clinicians makes it an ideal place to drive impactful research in precision medicine."

How did you experience the recruitment process at KI?
"I found the recruitment process to be thorough and well-structured. It was a valuable experience, requiring me to clearly define my scientific vision and research goals. It was evident that the evaluation went beyond academic merits, placing strong emphasis on potential, vision and the ambition to contribute to advancing research in Sweden, yet with international impact."

What strengths do you see in KI’s research environment?
"A key strength is the depth of clinical expertise in my field, with many human geneticists gathered in one place. Combined with world-class infrastructure at SciLifeLab, it offers a unique environment where strong international research can be directly translated into meaningful benefits for patients."

What do you hope to contribute during your time as an Assistant Professor at KI?
"I aim to improve genetic diagnostics and contribute to ensure that new advancements in research reach clinical practice. I also look forward to advancing research that supports a data-driven era in healthcare, where genetic precision medicine enables earlier intervention and even prevention of disease."